FDA issued its first warning letter to a dispenser (a medical spa) for violating the Drug Supply Chain Security Act (DSCSA), including failing to source products from authorized trading partners and BPC 157: Experimental Peptide Creates Risk for Athletes FDA takes first step in possible reversal of ban on some peptides The Washington Post Injectable Peptides: Out of the Back Alley and Into the Light? Berkley Lifesciences Is BPC 157 Banned? Oral vs. Injectable Forms Explained